The PPARγ agonist pioglitazone prevents TGF-β induced renal fibrosis by repressing EGR-1 and STAT3.

MLA

Németh, Ágnes, et al. “The PPARγ Agonist Pioglitazone Prevents TGF-β Induced Renal Fibrosis by Repressing EGR-1 and STAT3.” BMC Nephrology, vol. 20, no. 1, July 2019, p. 245. EBSCOhost, https://doi.org/10.1186/s12882-019-1431-x.

APA

Németh, Á., Mózes, M. M., Calvier, L., Hansmann, G., & Kökény, G. (2019). The PPARγ agonist pioglitazone prevents TGF-β induced renal fibrosis by repressing EGR-1 and STAT3. BMC Nephrology, 20(1), 245. https://doi.org/10.1186/s12882-019-1431-x

Chicago

Németh, Ágnes, Miklós M Mózes, Laurent Calvier, Georg Hansmann, and Gábor Kökény. 2019. “The PPARγ Agonist Pioglitazone Prevents TGF-β Induced Renal Fibrosis by Repressing EGR-1 and STAT3.” BMC Nephrology 20 (1): 245. doi:10.1186/s12882-019-1431-x.